
Clean-label nutrition brand TruNativ has raised US$30 million (around ₹290 crore) in a Series B funding round led by US-based investor OrbiMed. The round includes both fresh investment in the company and the sale of shares by some early investors.
The company plans to use the funding to expand its distribution network, grow its product range and set up a new research and development (R&D) centre. These steps will help TruNativ reach more customers and improve its offerings.
TruNativ will also use the funds to expand its B2B2C ingredients business, which supplies nutrition products to other consumer brands in India. This will strengthen its presence in the broader nutrition supply chain.
“After the pandemic, people have become aware of their nutritional needs, but are struggling to meet them. So our entire focus has been to integrate nutrition into people's daily lives instead of forcing them to do a hard shift,” said Pranav Malhotra.
Dr Sunny Sharma, senior managing director, OrbiMed Asia, said, “We share Pranav’s passion for improving nutrition nationwide and enhancing health outcomes through healthier dietary habits.”
Founded in 2019 by Mamta and Pranav Malhotra, TruNativ, co-founded by Eeshaan Merchant, sells nutrition products for everyday use at home. These include protein and fibre sachets that can be mixed into food while cooking, as well as a natural monk fruit sweetener, which is its most popular product.
The company has also started offering collagen supplements and plans to introduce more vitamin-based products in the future.
In the near term, TruNativ wants to expand into water-soluble protein products and other macronutrient supplements.
TruNativ earned ₹130 crore in revenue in FY26, which is a 350% increase compared to about ₹37 crore in the previous year. The company now aims to reach ₹200 crore in revenue in FY27.
Read Also- Beltone partners with Telda to boost digital investing in Egypt









